United States HR 5958: Drug-price Transparency for Consumers Act of 2023

Status: Referred to the Subcommittee on Health. (as of 2024-12-17)

State: United States · Session: 118 · Bill: HR 5958

Sponsors: Abigail Davis Spanberger, Zachary Nunn

View United States HR 5958 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.